These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 17315256)

  • 1. Antivascular therapies: targets beyond the vessel wall.
    Temming K; Kok RJ
    ChemMedChem; 2007 Apr; 2(4):433-5. PubMed ID: 17315256
    [No Abstract]   [Full Text] [Related]  

  • 2. In-silico fragment-based identification of novel angiogenesis inhibitors.
    Dakshanamurthy S; Kim M; Brown ML; Byers SW
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4551-6. PubMed ID: 17591441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel role for a familiar protein in apoptosis induced by proteasome inhibition.
    McConkey DJ
    Cancer Cell; 2008 Jul; 14(1):1-2. PubMed ID: 18598936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticulate drugs for the manipulation of angiogenesis.
    Millar TM; Kanaras AG
    Ther Deliv; 2013 Oct; 4(10):1217-9. PubMed ID: 24116904
    [No Abstract]   [Full Text] [Related]  

  • 5. 14-Membered macrocyclic ring-derived toolbox: the identification of small molecule inhibitors of angiogenesis and early embryo development in zebrafish assay.
    Aeluri M; Pramanik C; Chetia L; Mallurwar NK; Balasubramanian S; Chandrasekar G; Kitambi SS; Arya P
    Org Lett; 2013 Feb; 15(3):436-9. PubMed ID: 23331174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel 2,3-dihydro-1,4-benzoxazines as potent and orally bioavailable inhibitors of tumor-driven angiogenesis.
    La DS; Belzile J; Bready JV; Coxon A; DeMelfi T; Doerr N; Estrada J; Flynn JC; Flynn SR; Graceffa RF; Harriman SP; Larrow JF; Long AM; Martin MW; Morrison MJ; Patel VF; Roveto PM; Wang L; Weiss MM; Whittington DA; Teffera Y; Zhao Z; Polverino AJ; Harmange JC
    J Med Chem; 2008 Mar; 51(6):1695-705. PubMed ID: 18311900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update of new targets for cancer treatment: vessels and matrix.
    Bicknell R
    Ann Oncol; 2002; 13 Suppl 4():25-8. PubMed ID: 12401662
    [No Abstract]   [Full Text] [Related]  

  • 8. Streptopyrrolidine, an angiogenesis inhibitor from a marine-derived Streptomyces sp. KORDI-3973.
    Shin HJ; Kim TS; Lee HS; Park JY; Choi IK; Kwon HJ
    Phytochemistry; 2008 Sep; 69(12):2363-6. PubMed ID: 18649901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of antivascular therapy and targeted treatment in the clinic.
    Dahl O; Borkamo ED; Fluge O
    Int J Hyperthermia; 2008 Feb; 24(1):97-110. PubMed ID: 18214773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenesis: molecular mechanisms of activation, promotion and maintenance.
    Bikfalvi A
    J BUON; 2007 Sep; 12 Suppl 1():S59-66. PubMed ID: 17935279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenesis: an organizing principle for drug discovery?
    Folkman J
    Nat Rev Drug Discov; 2007 Apr; 6(4):273-86. PubMed ID: 17396134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Historical Overview of In Vivo and In Vitro Angiogenesis Assays.
    Cimpean AM; Raica M
    Methods Mol Biol; 2021; 2206():1-13. PubMed ID: 32754806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pericytes and ocular diseases.
    Motiejūnaite R; Kazlauskas A
    Exp Eye Res; 2008 Feb; 86(2):171-7. PubMed ID: 18078933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thrombosis of stents with an antiproliferative coating. Review of the literature].
    Krylov AL
    Angiol Sosud Khir; 2009; 15(1):59-66. PubMed ID: 19791576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-angiogenic activities of nucleosides and nucleotides and their structure-activity relationship.
    Tsukamoto I; Konishi R; Kubota Y; Tokuda M; Sakakibara N; Maruyama T
    Nucleic Acids Symp Ser (Oxf); 2007; (51):437-8. PubMed ID: 18029774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Argyrin a reveals a critical role for the tumor suppressor protein p27(kip1) in mediating antitumor activities in response to proteasome inhibition.
    Nickeleit I; Zender S; Sasse F; Geffers R; Brandes G; Sörensen I; Steinmetz H; Kubicka S; Carlomagno T; Menche D; Gütgemann I; Buer J; Gossler A; Manns MP; Kalesse M; Frank R; Malek NP
    Cancer Cell; 2008 Jul; 14(1):23-35. PubMed ID: 18598941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasoinhibins: novel inhibitors of ocular angiogenesis.
    Clapp C; Thebault S; Arnold E; García C; Rivera JC; de la Escalera GM
    Am J Physiol Endocrinol Metab; 2008 Oct; 295(4):E772-8. PubMed ID: 18544641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semisynthesis and pharmacological activities of Tetrac analogs: angiogenesis modulators.
    Bridoux A; Cui H; Dyskin E; Yalcin M; Mousa SA
    Bioorg Med Chem Lett; 2009 Jun; 19(12):3259-63. PubMed ID: 19427201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockage of the formation of new blood vessels by recombinant human endostatin contributes to the regression of rat adjuvant arthritis.
    Yue L; Shen YX; Feng LJ; Chen FH; Yao HW; Liu LH; Wu Q; Wang H
    Eur J Pharmacol; 2007 Jul; 567(1-2):166-70. PubMed ID: 17490637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of angiogenesis-relevant receptor tyrosine kinases by sulindac analogues.
    Gourzoulidou E; Carpintero M; Baumhof P; Giannis A; Waldmann H
    Chembiochem; 2005 Mar; 6(3):527-31. PubMed ID: 15696596
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.